CELLDEX THERAPEUTICS INC
CLDX·15117B202·US·Common Stock·Healthcare - Biotechnology-13D/G
CLDX (CELLDEX THERAPEUTICS INC) is held by 128 institutional investors as of Q2 2026. Largest holders: WELLINGTON MANAGEMENT GROUP LLP ($355.1M), BlackRock, Inc. ($260.6M), PRICE T ROWE ASSOCIATES INC /MD/ ($174.3M). Net institutional sentiment: Bullish.
128
Holders
(11 Elite)
$2.1B
Total Value
71% (124)
Consensus
88 buying - 36 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders Jun 18, 2024 · Activists Oct 7, 2026 · Congress none
ActivistKYKynam Capital Management, LP6.8%Aug 14, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 136
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer